AIHealthcare

AbCellera Biologics Inc. is a Vancouver-based, publicly traded clinical-stage biotechnology company that combines single-cell biology, microfluidics, high-throughput sequencing, bioinformatics, laboratory automation, data science, and machine learning to discover and develop antibody-based medicines. Its platform searches, decodes, and analyzes natural immune responses to identify therapeutic antibody candidates, while its business model combines partnerships with pharmaceutical and biotechnology companies and development of an internal pipeline. AbCellera reports more than 100 completed therapeutic-antibody discovery programs and partnerships with companies including Eli Lilly, Moderna, GSK, Vertex, and Jazz Pharmaceuticals. The company is transitioning from primarily a discovery-platform partnership model toward advancing company-owned clinical programs in endocrinology, women’s health, immunology, oncology, and other areas.